NATIONAL BANK OF CANADA /FI/

Bank

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 926171 MONTREAL, A8

Position in BIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$25,087,500

+$23,583,211 QoQ

Shares Held

90,000

+1534.0% QoQ

Ownership

0.336%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

NATIONAL BANK OF CANADA /FI/ holds $684,634,284 across 39 Medical Devices names. BIO ranks #8 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	400,732	$131,676,526
2	ABT	Abbott Laboratories	1,153,074	$118,386,105
3	DXCM	Dexcom Inc	1,870,971	$117,496,978
4	MDT	Medtronic plc	940,505	$81,494,756
5	BSX	Boston Scientific Corp	1,260,894	$79,121,096
6	NEOG	Neogen Corp	3,500,000	$32,515,000
7	GEHC	GE HealthCare Technologies Inc.	369,443	$26,296,952
8	BIO	Bio-Rad Laboratories, Inc. This page	90,000	$25,087,500

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,087,500	90,000	+1534.0%	Shares	Defined	2026-05-15
2024-06-30	$1,504,289	5,508	+19.1%	Shares	Defined	2024-08-02
2024-03-31	$1,598,956	4,623	-70.6%	Shares	Defined	2024-05-13
2023-12-31	$5,080,349	15,734	-13.2%	Shares	Defined	2024-02-06
2023-09-30	$6,499,055	18,131	+5.1%	Shares	Defined	2023-10-10
2023-06-30	$6,538,681	17,247	+1059.9%	Shares	Defined	2023-07-26
2023-03-31	$712,302	1,487	+138.3%	Shares	Defined	2023-04-12
2022-12-31	$262,384	624	-56.0%	Shares	Defined	2023-01-24
2022-09-30	$591,504	1,418	-6.6%	Shares	Defined	2022-10-13
2022-06-30	$751,410	1,518	-81.0%	Shares	Defined	2022-07-28
2022-03-31	$4,510,909	8,009	-27.8%	Shares	Defined	2022-05-05
2021-12-31	$8,378,515	11,089	—	Shares	Defined	2022-01-24
No filing history on record for this holder in this stock.